Target Cells is a biotech start-up founded by scientists from Poland and the USA specialising in stem cell research and cardiac regeneration.
Our goal is the comprehensive development of regenerative medicine applications for targeted stem cell-based products for myocardial repair.
We aim to commercialise products which will enable the evaluation of the efficacy of targeted stem cell delivery to selected human tissues under in vitro assay conditions.
Company Details
- Founded
- -
- Address
- Cracow, Lesser Poland 31-545, Pl
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://targetcells.pl/
- Keywords
- stem cells, regenerative medicine, stem cell therapy, targeted stem cell delivery, komórki macierzyste, medycyna regeneracyjna, terapie komórkami macierzystymi, celowane aplikacje komórek macierzystych, stem cell heart repair, regeneracja serca komórkami macierzystymi, regenerative cardiology, kardiologia regeneracyjna, stem cell binding assay, test wiązania komórek macierzystych.
- HQ
- Cracow, Lesser Poland
Target Cells Questions
Target Cells's website is https://targetcells.pl/
Target Cells's LinkedIn profile is https://pl.linkedin.com/company/target-cells
Target Cells's industry is
Biotechnology Research
Target Cells's top competitors are
Abastroke,
Project42,
Vaxican,
Tg Pharma - Demophta,
Vivid Mind,
Inventro,
P42med,
Apixmed,
Pikralida,
Intodna.
Target Cells's categories are Biotechnology Research
Target Cells's founding year is 2023
